2-(2-(4-Nonylphenoxy)ethoxy)ethanol
Names
[ CAS No. ]:
9016-45-9
[ Name ]:
2-(2-(4-Nonylphenoxy)ethoxy)ethanol
[Synonym ]:
Synperonic NX
2-[2-(4-Nonylphenoxy)ethoxy]ethanol
Ethanol, 2-[2-(4-nonylphenoxy)ethoxy]-
Agral
Ethanol, 2-(2-(4-nonylphenoxy)ethoxy)-
Agral Plus
Ethoxylated nonylphenol
2-(2-(4-Nonylphenoxy)ethoxy)ethanol
MFCD00132851
Alfenol
Chemical & Physical Properties
[ Density]:
1.0±0.1 g/cm3
[ Boiling Point ]:
436.1±30.0 °C at 760 mmHg
[ Melting Point ]:
44-46 °C
[ Molecular Formula ]:
C19H32O3
[ Molecular Weight ]:
308.456
[ Flash Point ]:
217.6±24.6 °C
[ Exact Mass ]:
308.235138
[ LogP ]:
5.79
[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C
[ Index of Refraction ]:
1.496
[ Storage condition ]:
-20°C
[ Water Solubility ]:
Do you have solubility information on this product that you would like to share
Safety Information
[ Symbol ]:
GHS05, GHS07, GHS09
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H302-H318-H400
[ Precautionary Statements ]:
P273-P280-P305 + P351 + P338
[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
Xi,N,Xn
[ Risk Phrases ]:
41-38-37-36/37/38-50-22
[ Safety Phrases ]:
26-39-36-61
[ RIDADR ]:
UN 3082 9 / PGIII
[ WGK Germany ]:
2
[ RTECS ]:
WZ4750000
[ Hazard Class ]:
9.0
[ HS Code ]:
34021300
Articles
Oncotarget 6(4) , 2134-47, (2015)
Though metastatic cancers often initially respond to genotoxic therapeutics, acquired resistance is common. In addition to cytotoxic effects on tumor cells, DNA damaging agents such as ionizing radiat...
A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.MAbs 8 , 74-86, (2015)
Monomeric IgA has been proposed as an alternative antibody format for cancer therapy. Here, we present our studies on the production, purification and functional evaluation of anti-HER2 IgA antibodies...
Viriditoxin regulates apoptosis and autophagy via mitotic catastrophe and microtubule formation in human prostate cancer cells. Kundu S, Kim TH, Yoon JH, et al.Int. J. Oncol. 45(6) , 2331-40, (2014)